By Sequora Research Team · Updated October 2026
A lyophilized peptide is a peptide that has been freeze-dried: frozen, then dried under vacuum so the ice turns straight to vapor. What is left is a dry powder or “cake” in a sealed vial. Removing the water slows the chemical reactions that break peptides down in solution.
This guide covers how freeze-drying works, what normal powder looks like, how dry peptides are stored, and what degrades them. It does not cover preparing solutions. For the solvent side, see our separate guide to bacteriostatic water for peptides.
What is lyophilization?
Lyophilization is the technical name for freeze-drying. It runs in three stages inside a freeze-dryer, and each stage has a different job [R1].
| Stage | What happens | Typical conditions reported |
|---|---|---|
| 1. Freezing | The peptide solution is frozen solid. Ice crystals form and the peptide is concentrated between them. | Final freezing temperature around −40 °C to −45 °C |
| 2. Primary drying | Under vacuum, the ice sublimes: it turns directly from solid to vapor without melting. | Chamber pressure typically 50–200 mTorr; product kept just below its collapse temperature |
| 3. Secondary drying | Shelf temperature is raised to remove water still bound to the solid (desorption). | Amorphous products often dried at 40–50 °C to below 0.5% water by weight |
Freezing sets the structure of the final cake. Primary drying removes most of the water and usually takes the longest. Secondary drying is described as the more straightforward step [R1].
Drier is not always better. The same review notes that some products are more stable at an intermediate water content [R1]. Each formulation has its own target.
Why research peptides are supplied lyophilized
Water drives many of the reactions that degrade peptides. A protein stability review states that the dried form is preferable to the dissolved form for research use, because it avoids in-solution breakdown and hydrolysis [R2].
Deamidation is a good example. Asparagine deamidation speeds up in neutral and alkaline solution, especially at Asn-Gly and Asn-Ser sites [R2]. Taking water out of the system slows reactions like this.
Freeze-drying also gives a defined, weighable solid in a sealed vial. That makes batch labelling and testing simpler. It is why high purity research peptides are almost always sold as powder rather than as ready-made solutions.
Sequora ships every product as a sealed, labelled, lyophilized vial with a batch code to the US and Canada. Delivery details are on our shipping page.
What lyophilized peptide powder looks like in the vial
A lyophilized peptide vial usually holds a white or off-white solid at the bottom. It can look very different from one vial to the next, and most of those differences are normal.
Fluffy cake vs. collapsed cake
An “ideal” cake is a light, porous plug that keeps the shape of the frozen fill. A cake can also shrink, crack, or partly collapse into a thin film or glassy patch. Collapse happens when the product warms above its critical temperature during drying [R1].
Appearance is not the same as quality. The review reports that collapse does not necessarily cause potency loss. It also states that a cake can meet specification without being visually “elegant” [R1]. Batch testing, not looks, tells you what is in the vial.
Why the amount of powder varies
- Fill amount. A 10 mg vial holds visibly more solid than a 5 mg vial of the same peptide.
- Excipients. Some formulations include bulking agents such as mannitol or glycine, which add volume and support the cake structure [R1].
- Handling in transit. A cake can break up into loose powder or stick to the vial wall when shaken.
- Peptide properties. Different sequences dry into different textures.
A cake that looks wet, sticky, or discolored is a different matter. That can point to moisture getting in, and it is worth checking against the batch documentation.
Lyophilized peptide storage: cold, dry and dark
Dry powder is more stable than solution, but it still needs care. Handling guidance from the UK National Institute for Biological Standards and Control gives a consistent set of rules [R5]:
- Cold. Store lyophilized peptides at −20 °C for the long term.
- Dark. Keep vials away from bright light.
- Dry. Moisture greatly reduces the long-term stability of solid peptides. Keep vials tightly capped and reseal them promptly after opening.
- Warm before opening. Let a cold vial reach room temperature before you open it.
The last point is easy to skip. A cold vial opened in room air invites moisture onto a powder that may already be hygroscopic. Waiting a few minutes avoids that.
Heat also matters. The protein stability review notes that higher temperature speeds up both oxidation and deamidation [R2]. Our storage guidance on the Quality & Testing page summarises these rules for Sequora vials.
What degrades peptides
Most peptide degradation comes from a short list of chemical routes. Some depend on sequence, and some on how the material is handled.
| Degradation route | Residues most affected | Main triggers |
|---|---|---|
| Moisture uptake and hydrolysis | Whole peptide; hygroscopic sequences most at risk | Humid air, opening cold vials, loose caps |
| Oxidation | Met (most susceptible), Cys, Trp, His, Tyr | Oxygen, light, trace metal ions, peroxides |
| Deamidation | Asn, Gln (fastest at Asn-Gly, Asn-Ser) | Neutral or alkaline solution, heat |
| Light-induced damage | Tyr, Trp, Cys, His | UV light, singlet oxygen |
| Freeze–thaw stress | Peptides and proteins in solution | Repeated freezing and thawing of solutions |
Oxidation of Met, Cys and Trp
Methionine is the residue most prone to oxidation, and tryptophan, histidine, cysteine and tyrosine are also involved. Exposure to oxygen during shipping and storage, light and metal ions are named triggers [R2]. Cysteine and methionine oxidation products are also found as impurities in synthetic peptides [R3].
Deamidation of Asn and Gln
Deamidation turns the side-chain amide of Asn or Gln into a carboxyl group. For Asn, it runs through a succinimide intermediate that converts to isoAsp and Asp [R2]. It adds about 1 Da, so mass spectrometry can detect it [R3].
Repeated freeze–thaw of solutions
Freezing a solution is not gentle. In a study using two model proteins in phosphate buffer, cooling from 20 °C to −25 °C lowered the pH by about 3 units. The shift came from buffer salt crystallizing, and it coincided with a sharp rise in aggregate particles [R4]. Handling guidance advises avoiding repeated freeze–thaw cycles for peptide solutions [R5]. Keeping material dry until needed sidesteps this problem.
Lyophilized Peptide FAQ
What is a lyophilized peptide?
It is a peptide that has been freeze-dried into a solid powder. Freezing and vacuum drying remove the water, which slows degradation reactions that happen in solution.
Is lyophilized the same as freeze-dried?
Yes. Lyophilization is the technical term for freeze-drying. Both describe freezing followed by drying under vacuum.
Does lyophilized peptide powder need to be refrigerated?
For long-term storage, handling guidance recommends −20 °C, away from light, in a tightly closed vial [R5]. Let the vial reach room temperature before opening.
Why does the powder in my vial look shrunken or collapsed?
Cake shrinkage and partial collapse are common outcomes of the drying process. Published work reports that collapse does not necessarily mean a loss of potency [R1]. Check the batch COA rather than relying on appearance.
Why do two lyophilized peptide vials look different?
Fill amount, excipients, sequence and handling in transit all change how the solid looks. Learn how to check the batch paperwork in how to read a peptide COA.
Every compound in our research peptide catalog ships as a lyophilized powder in a sealed vial.
References
- Tchessalov S, Maglio V, Kazarin P, Alexeenko A, Bhatnagar B, Sahni E, Shalaev E. Practical advice on scientific design of freeze-drying process: 2023 update. Pharmaceutical Research. 2023;40(10):2433–2455. doi:10.1007/s11095-023-03607-9
- Akbarian M, Chen SH. Instability challenges and stabilization strategies of pharmaceutical proteins. Pharmaceutics. 2022;14(11):2533. doi:10.3390/pharmaceutics14112533
- D’Hondt M, Bracke N, Taevernier L, Gevaert B, Verbeke F, Wynendaele E, De Spiegeleer B. Related impurities in peptide medicines. Journal of Pharmaceutical and Biomedical Analysis. 2014. PMID: 25044089. doi:10.1016/j.jpba.2014.06.012
- Thorat AA, Munjal B, Geders TW, Suryanarayanan R. Freezing-induced protein aggregation: role of pH shift and potential mitigation strategies. Journal of Controlled Release. 2020;323:591–599. doi:10.1016/j.jconrel.2020.04.033
- Peptide storage. National Institute for Biological Standards and Control (NIBSC), peptide library guidance. Accessed October 2026. Technical note
For laboratory research use only. Not for human or veterinary use.